Leuprolide

( DrugBank: Leuprolide / KEGG DRUG: Leuprolide acetate, Leuprorelin, Leuprolide mesylate )

---

4 diseases

1. Spinal and bulbar muscular atrophy

---

Clinical trials : 19 / Drugs : 16 - (DrugBank : 7) / Drug target genes : 10 - Drug target pathways : 18 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

2. Amyotrophic lateral sclerosis

---

Clinical trials : 786 / Drugs : 550 - (DrugBank : 182) / Drug target genes : 170 - Drug target pathways : 232 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

3. Spinal muscular atrophy

---

Clinical trials : 297 / Drugs : 143 - (DrugBank : 32) / Drug target genes : 54 - Drug target pathways : 82 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

76. Pituitary gonadotropin secretion hyperthyroidism

---

Clinical trials : 38 / Drugs : 36 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 19 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries